Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
Eagle Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Eagle Pharmaceuticals reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, six executives at Eagle Pharmaceuticals received on average a compensation package of $3.9M, a 5% decrease compared to previous year.
Average pay of disclosed executives at Eagle Pharmaceuticals
Scott Tarriff, Chief Executive Officer, received $9.5M in total, which increased by 20% compared to 2019. 48% of Tarriff's compensation, or $4.6M, was in option awards. Tarriff also received $555K in non-equity incentive plan, $822K in salary, $3.5M in stock awards, as well as $23K in other compensation.
For fiscal year 2020, the median employee pay was $254,007 at Eagle Pharmaceuticals. Therefore, the ratio of Scott Tarriff's pay to the median employee pay was 37 to one.
Pete A. Meyers, Chief Financial Officer, received a compensation package of $3.8M, which increased by 42% compared to previous year. 39% of the compensation package, or $1.5M, was in option awards.
David Pernock, Chief Operating Officer, earned $3.8M in 2020, a 19% increase compared to previous year.
Adrian J. Hepner, Chief Medical Officer, received $3.5M in 2020, which increases by 31% compared to 2019.
Brian Cahill, Chief Financial Officer, earned $1.8M in 2020.
Judith Ng-Cashin, Chief Medical Officer, received $951K in 2020.
Related executives
Scott Tarriff
Eagle Pharmaceuticals
Chief Executive Officer
Brian Cahill
Eagle Pharmaceuticals
Chief Financial Officer
Pete Meyers
Eagle Pharmaceuticals
Chief Financial Officer
David Pernock
Eagle Pharmaceuticals
Chief Operating Officer
Judith Ng-Cashin
Eagle Pharmaceuticals
Chief Medical Officer
Adrian Hepner
Eagle Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 30, 2021.